SentreHEART Announces 400th Patient Enrollment in the Landmark Trial

  • September 5, 2018

Redwood City, CA- September 5, 2018 (BUSINESS WIRE) SentreHEART, Inc., manufacturer of the LARIAT® Suture Delivery Device (LARIAT) for percutaneous left atrial appendage (LAA) closure announces enrollment of the 400th patient in the prospective, multi-center, randomized controlled Trial known as…

Read More

SentreHEART Announces Participation at Heart Rhythm 2017

  • May 9, 2017

Redwood City, CA May 9, 2017 – SentreHEART, Inc., the manufacturer of the LARIAT+® Suture Delivery Device and the new LARIAT-RSTM will be participating in the 2017 Heart Rhythm Scientific Sessions (HR 2017) being held in Chicago, Illinois May 10-13th. The…

Read More